Clinical trial
The SILVER Study: Systolic Hypertension Interaction With Left Ventricular…
NCT00045994 · Synvista Therapeutics, Inc, Industry · Completed
Key facts
| NCT number | NCT00045994 |
|---|---|
| Title | The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling |
| Official title | Systolic and Pulse Pressure Hemodynamic Improvement By Restoring Elasticity: The SILVER Study |
| Lead sponsor | Synvista Therapeutics, Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension, Hypertrophy, Left Ventricular |
| Intervention type | Drug |
| Interventions | ALT-711 |
| Enrollment | 180 |
| Start date | Aug 1, 2001 |
| Primary completion | Jan 1, 2002 |
| Completion | Jun 1, 2003 |
| First posted | Sep 19, 2002 |
| Last update posted | Jul 29, 2009 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: